SEC Form 4/A · accession 0001062993-18-003581
BIOSPECIFICS TECHNOLOGIES CORP · BSTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Paul Gitman
Director
Period of report
Aug 27, 2018
Accepted (ET)
Aug 29, 2018 · 5:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875622
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par valueF1 | Aug 27, 2018 | S | 10,000 | $50.1144 | D | 30,000 | D | |
| Common Stock, $0.001 par valueF2 | Aug 28, 2018 | S | 5,000 | $48.8831 | D | 25,000 | D | |
| Common Stock, $0.001 par valueF3 | Aug 29, 2018 | S | 4,000 | $49.7946 | D | 21,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The selling price of $50.1144 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $49.23 to $52.19. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F2The selling price of $48.8831 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $48.68 to $49.41. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The selling price of $49.7946 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $49.35 to $50.00. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. This amendment is being provided to correct the number of shares disposed of for the transactions reported on this line